Results for 'checkmate-067'
Sarah A. Weiss, MD, and Harriet Kluger, MD
CheckMate-067: Raising the Bar for the Next Decade in Oncology
checkmate-067, nivolumab, oncology, relativity-047
Historically, few effective systemic therapies were available for advanced melanoma, but recent advancements have led to significant progress. In 2015, the US FDA approved the combination of ipilimumab and nivolumab based on the results of the CheckMate-067 trial. CheckMate-067 demonstrated lo…
Dec 2nd • 2 mins read